default author photo

Lionel Falchero

affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (2)

Impact of upfront stereotactic brain radiotherapy combined with first-line chemo-immunotherapy on overall survival in patients with metastatic NSCLC: a multicentre study

Number of pages: 23 Posted: 22 Apr 2026
University of Nantes - CHU Nantes, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Centre Léon Bérard, affiliation not provided to SSRN, affiliation not provided to SSRN, Université de Rennes 1 - CHU de Rennes, CHU de Brest, Centre Hospitalier Intercommunal de Créteil, University of Bordeaux - CHU de Bordeaux, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospices Civils de Lyon, affiliation not provided to SSRN, Institut de Cancérologie de l'Ouest, Grenoble Alpes University Hospital and University of Nantes - CHU Nantes
Downloads 26 (1,559,710)

Abstract:

Loading...

Non-small Cell Lung Cancer, brain metastases, chemo-immunotherapy, Radiotherapy, stereotactic radiotherapy

Impact of upfront stereotactic brain radiotherapy combined with first-line chemo-immunotherapy on overall survival in patients with metastatic NSCLC: a multicentre study

Number of pages: 23 Posted: 09 Jul 2026
University of Nantes - CHU Nantes, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Centre Léon Bérard, affiliation not provided to SSRN, affiliation not provided to SSRN, Université de Rennes 1 - CHU de Rennes, CHU de Brest, Centre Hospitalier Intercommunal de Créteil, University of Bordeaux - CHU de Bordeaux, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospices Civils de Lyon, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Grenoble Alpes University Hospital and University of Nantes - CHU Nantes
Downloads 20

Abstract:

Loading...

Non-small cell lung cancer, brain metastases, chemo-immunotherapy, Radiotherapy, stereotactic radiotherapy

2.

A multicenter phase 2 study evaluating Denosumab in combination with Nivolumab as second-line therapy for patients with stage IV non-small–cell lung cancer with bone metastases, DENIVOS-GFPC 06-2017

Number of pages: 21 Posted: 28 Apr 2026
Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Centre Hospitalier Intercommunal de Créteil, Centre Hospitalier Pierre Bénite - Clinical Research Unit, CHU Rennes, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, CHU de Brest, University of Angers - CHU Angers, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Centre Hospitalier de Perpignan, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Normandie Université, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 31 (1,424,331)

Abstract:

Loading...

non-small cell lung cancer, Bone metastasis, immune checkpoint inhibitor, anti-resorptive agent, skeletal-related events